CONTRALATERAL BREAST CANCER

This adverse event was reported 206 times

CONTRALATERAL BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen [EPC] 165 0.0009
1 Progesterone [EPC] 6 0.0003
2 Aromatase Inhibitor [EPC] 15 0.0001
3 HER2/neu Receptor Antagonist [EPC] 6 0.0001
4 Androgen [EPC] 2 0.0001
5 Bile Acid [EPC] 1 0.0000
6 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
7 Parathyroid Hormone Analog [EPC] 1 0.0000
8 Alkylating Drug [EPC] 2 0.0000
9 Leukocyte Growth Factor [EPC] 1 0.0000
See all drug classes enriched for association with CONTRALATERAL BREAST CANCER